tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Posts Tagged 'Acquisition'

After Pancreatic Cancer, Eli Lilly and Nuvilex Could Battle Over Diabetes Treatment

After Pancreatic Cancer, Eli Lilly and Nuvilex Could Battle Over Diabetes Treatment

Written by ι Stock Market Media Group Staff — December 5, 2013

Eli Lilly & Co. (NYSE: LLY) has parlayed its cancer drug Gemzar® or gemcitabine into well over $10 billion since it gained approval to treat advanced, inoperable pancreatic cancer back in 1996.  Meanwhile, Nuvilex, Inc. (OTCQB: NVLX) has its eyes on a piece of that billion dollar pie with the company’s live-cell encapsulation based treatment for pancreatic cancer.  But, it may be another disease that has these two biotech’s going head ...

Read More →
0

Investors Confidently Back Nuvilex’s Acquisition of Diabetes Technology

Investors Confidently Back Nuvilex’s Acquisition of Diabetes Technology

Written by ι Stock Market Media Group Staff — November 12, 2013

Nuvilex, Inc. (OTCQB: NVLX) announced last week that it has acquired the exclusive worldwide rights to a cellulose-based live-cell encapsulation technology for the development of treatments for diabetes.  In order to pull off the acquisition, Nuvilex had to convince investors to part with $1.5 million dollars in cash.  One wouldn’t think this a hard sell given the acquisition could lead to a multi-billion dollar treatment for the company.  And, you’d ...

Read More →
0

Nuvilex, Inc. Investing Big in What Could Be Its Billion Dollar Future

Nuvilex, Inc. Investing Big in What Could Be Its Billion Dollar Future

Written by ι Stock Market Media Group Staff — August 20, 2013

Nuvilex, Inc. (OTCQB: NVLX) just acquired oncology assets that make this small Silver Spring, Maryland, biotech worth more today than it was just a month ago.  This investment could prove to be a genius move on the scale one might see from the “Oracle of Omaha,” Warren Buffet.  Make no mistake about it, Nuvilex is investing big in its own future and doing so piece by piece. 

One would have to be ...

Read More →
0

Nuvilex, Inc. to Control 2 of the Big 3 Multi Billion Dollar Drug Markets with Technology

Nuvilex, Inc. to Control 2 of the Big 3 Multi Billion Dollar Drug Markets with Technology

Written by ι Stock Market Media Staff — August 7, 2013

Nuvilex, Inc. (OTCQB: NVLX) is methodically laying the foundation today for what should be a very busy and promising future tomorrow.  After making a blockbuster deal to acquire Bio Blue Bird and its worldwide licenses associated with the live-cell encapsulation platform technology to develop treatments for all cancer types, Nuvilex announced this week that it now intends to do the same thing with diabetes. 

When Nuvilex pulls off this acquisition, it will ...

Read More →
0

Nuvilex, Inc. Strengthens its Hand in the Cancer Arena with Purchase of Assets

Nuvilex, Inc. Strengthens its Hand in the Cancer Arena with Purchase of Assets

Written by ι Stock Market Media Group Staff — July 30, 2013

Nuvilex, Inc. (OTCQB: NVLX) became a much more valuable company in July when it closed a deal it was fully prepared to pay a great deal more money for, but while it spent far fewer dollars, the assets it purchased could prove to fetch a price tag exponentially greater than the $1.5 million the company paid.  In addition, Nuvilex originally set aside 100 million of its common shares to negotiate a ...

Read More →
0

Nuvilex, Inc. Acquisition Could Be Steal of the Century and Worth Billions

Nuvilex, Inc. Acquisition Could Be Steal of the Century and Worth Billions

Written by ι Stock Market Media Group Staff — July 18, 2013

In a recently announced acquisition deal, Nuvilex, Inc. (OTCQB: NVLX), pulled off what can only be described as the steal of the century.  The company was able to secure a deal that allowed it to “cherry-pick” the exact piece of the pie Nuvilex wanted from another company.  And, what was the exact piece of the pie Nuvilex wanted – Bio Blue Bird AG (BBB) and more importantly, its worldwide licenses ...

Read More →
0
ContactUs.com